## Abstract The present investigation examined the neuroprotective benefits for combined trehalose administration with C17.2 neural stem cell transplantation in a transgenic mouse model of Huntington's disease (HD), R6/2. C17.2 neural stem cells have the potential of differentiating into a neuronal
Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington’s disease
✍ Scribed by Verena Johann; Johannes Schiefer; Christian Sass; Jörg Mey; Gary Brook; Alexander Krüttgen; Christiane Schlangen; Christian Bernreuther; Melitta Schachner; Marcel Dihné; Christoph M. Kosinski
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 949 KB
- Volume
- 177
- Category
- Article
- ISSN
- 0014-4819
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Embryonic stem cell (ESC)–derived products have emerged as a promising cell source for neuroregeneration. C17.2 neural precursor cells were noted to express genes of neurotrophins and neuroprotective factors and to be enable to enhance proliferation, neuritogenesis, and differentiation
Glutamate excitotoxicity has been suggested to contribute to the pathogenesis of Huntington's disease (HD). Riluzole is a substance with glutamate antagonistic properties that is used for neuroprotective treatment in amyotrophic lateral sclerosis and which is currently tested in clinical trials for
## Abstract Huntington's disease (HD) is a progressive, autosomal dominant neurodegenerative disease caused by an abnormally expanded CAG repeat in the HD gene. Ubiquitylated aggregates containing mutant huntingtin protein in neurons are hallmarks of HD. Misfolded mutant huntingtin monomers, oligom
## Abstract Dopaminergic (DA) grafts in rat models of Parkinson's disease (PD) have previously been derived from embryonic day (E) 14 grafts. Because there is an increasing interest in the restorative capacity of DA stem and progenitor cells, in the present study we examined the survival and early